Head-to-head study on efficacy and safety of Monoclonal Antibodies Against Calcitonin Gene-Related Peptide for Migraine

被引:0
|
作者
Russo, C. [1 ]
Braca, S. [1 ]
Sacca, F. [1 ]
机构
[1] Univ Federico II, Dept Neurol Sci Reprod & Odontostomatol Sci, Naples, Italy
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
EPO-576
引用
收藏
页码:684 / 684
页数:1
相关论文
共 50 条
  • [1] A head-to-head observational cohort study on the efficacy and safety of monoclonal antibodies against calcitonin gene-related peptide for chronic and episodic migraine
    Braca, S.
    Russo, C. V.
    Sacca, F.
    Stornaiuolo, A.
    Miele, A.
    De Simone, R.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [2] A head-to-head observational cohort study on the efficacy and safety of monoclonal antibodies against calcitonin gene-related peptide for chronic and episodic migraine
    Sacca, Francesco
    Braca, Simone
    Sansone, Mattia
    Miele, Angelo
    Stornaiuolo, Antonio
    De Simone, Roberto
    Russo, Cinzia Valeria
    HEADACHE, 2023, 63 (06): : 788 - 794
  • [3] Monoclonal antibodies against calcitonin gene-related peptide for the prophylaxis of migraine with aura
    Kim, B. K.
    Lee, H. C.
    Cho, S.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [4] Calcitonin gene-related peptide (CGRP) monoclonal antibodies for migraine
    Giffin, Nicola J.
    PRACTICAL NEUROLOGY, 2023, 23 (03) : 200 - +
  • [5] Safety efficacy and tolerability of the calcitonin gene-related peptide monoclonal antibodies for migraine prevention treatment of migraine, Kuwait experience
    Ashkanani, Hasan
    Al-Hashel, Jasem
    Ahmed, Samar
    Alroughani, Raed
    Alwazzan, Sawsan
    NEUROLOGY, 2021, 96 (15)
  • [6] Monoclonal Antibodies for Migraine: Preventing Calcitonin Gene-Related Peptide Activity
    Marcelo E. Bigal
    Sarah Walter
    CNS Drugs, 2014, 28 : 389 - 399
  • [7] Monoclonal Antibodies for Migraine: Preventing Calcitonin Gene-Related Peptide Activity
    Bigal, Marcelo E.
    Walter, Sarah
    CNS DRUGS, 2014, 28 (05) : 389 - 399
  • [8] Adherence and persistence associated with calcitonin gene-related peptide monoclonal antibodies compared to non-calcitonin gene-related peptide monoclonal antibodies treatments for prevention of migraine
    Foster, S. A.
    Manjelievskaia, J.
    Ford, J. H.
    Ye, W.
    Perry, A.
    Schuh, K.
    Wenzel, R.
    HEADACHE, 2021, 61 : 54 - 54
  • [9] Switching associated with initiation of calcitonin gene-related peptide monoclonal antibodies versus non-calcitonin gene-related peptide monoclonal antibodies treatments for prevention of migraine
    Foster, S. A.
    Manjelievskaia, J.
    Ford, J. H.
    Ye, W.
    Perry, A.
    Schuh, K.
    Wenzel, R.
    HEADACHE, 2021, 61 : 75 - 76
  • [10] Monoclonal antibodies against calcitonin gene-related peptide in chronic migraine: an adjusted indirect treatment comparison
    del Pilar Briceno-Casado, Maria
    David Gil-Sierra, Manuel
    Fenix-Caballero, Silvia
    FARMACIA HOSPITALARIA, 2020, 44 (05) : 212 - 217